Investigational Drug Information for Sitaxentan
✉ Email this page to a colleague
What is the development status for investigational drug Sitaxentan?
Sitaxentan is an investigational drug.
There have been 10 clinical trials for Sitaxentan.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Hypertension, Familial Primary Pulmonary Hypertension, and Pulmonary Arterial Hypertension. The leading clinical trial sponsors are Pfizer, Encysive Pharmaceuticals, and Institut National de la Santé Et de la Recherche Médicale, France.
Summary for Sitaxentan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,566 |
| WIPO Patent Applications | 983 |
| Japanese Patent Applications | 681 |
| Clinical Trial Progress | Phase 3 (2010-11-01) |
| Vendors | 47 |
Recent Clinical Trials for Sitaxentan
| Title | Sponsor | Phase |
|---|---|---|
| Drug Interaction Between Ritonavir And Sitaxsentan | Pfizer | Phase 1 |
| Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients | Pfizer | Phase 3 |
| A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses | Pfizer | Phase 1 |
Clinical Trial Summary for Sitaxentan
Top disease conditions for Sitaxentan
Top clinical trial sponsors for Sitaxentan
US Patents for Sitaxentan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
